In addition, five characteristic genes (CDKN1B, EGR1, FKBP5, GDF15, and MARCKS) have been preliminarily identified as sensitive potential biomarkers that could influence the development of DN by controlling ER stress. This evidence concerns the gene CDKN1B and liver dysplastic nodule.